Skip to main content
  • Displaying 20 - 30 of 55
  • First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last
HMGB1 as a Marker for Lung Cancer in High-Risk Populations
Glenn Simmons Jr., PhD, Assistant Professor, University of Minnesota Medical School Duluth
Tags: SciTalk cancer protein biomarkers

Recorded during the Keystone SymposiaSAB meeting:



June 17, 2017, Keystone, Colorado

Introduction to Vectors
Maureen Coetzee, PhD, University of the Witwatersrand
Tags: SciTalk Infectious Disease Pre Meeting Workshop Malaria education ePrimer vectors

Recorded on September, 10 2017


Pre-Meeting Workshop

Vectors, Pathogens and Diseases: Current Trends and Emerging Challenges

Sept 10 - Sept 14, 2017 | Durban, South Africa

This Keystone Symposia SciTalk was made possible by a grant from the


custom image

Understanding the scope and magnitude of Vector-Borne Pathogens
Josiane Etang, PhD, Justus Liebig University Giessen
Tags: SciTalk Infectious Disease Pre Meeting Workshop Malaria ePrimer vectors

Recorded on September, 10 2017


Pre-Meeting Workshop


Vectors, Pathogens and Diseases: Current Trends and Emerging Challenges

Sept 10 - Sept 14, 2017 | Durban, South Africa

This Keystone Symposia SciTalk was made possible by a grant from the

custom image

Bedside to Bench: From Frailty to Muscle Regeneration
Heewon Jung, MD, MSc, Korean Advanced Istitute of Science and Technology
Tags: SciTalk Aging regeneration developmental regenerative


Clinical importance of frailty on outcomes has been studied for the last decade in South Korea. Initially, operational concept of frailty has been validated, and then studies have been focused on comprehensive assessment of frailty in geriatric field. Afterwards, many brief tools which can screen frailty in various clinical settings have been developed, opening door to widespread access on frailty assessment. By these historical emergence of frailty assessment in clinical medicine, many clinicians and researchers other than geriatricians started to incorporate the concept of frailty in their field. Firstly, adoption and expansion of frailty research in clinical medicine connects geriatrics with many other specialties including surgeries, cardiology, and oncology, which deal with serious conditions commonly occurs in older people. Many observational studies showed that frailty in these people can lead to severe adverse events which might be unexpected with chronological age or traditional risk models. Therefore, assessing frailty status and modifying therapeutic strategy has become an important issue in many common conditions in older people. Furthermore, studies even started to include pre- or post-treatment prevention of frailty or functional decline in surgery field. Also, studies on frailty is becoming more systematic and large-scaled, with support of nationwide public health care system. In the past, observational and interventional studies on frailty has been confined in small sized community or geriatric clinic. Evidences from these studies lead to the nationwide efforts to develop guidelines to prevent frailty in older people. Lastly, concept of frailty which started as operational criteria in older people started to expand to preclinical and translational biomedicine researches. Researchers are developing tools to assess frailty in animals including rodents, and also establishing animal models with features of frailty. Preclinical research platforms from these efforts will provide tools to validate efficacy and mechanisms of specific therapeutic intervention on frailty. Since frailty is rather recently suggested clinical concept, there are many unanswered questions. Nevertheless, since there is ever inrrpASinn demand for the prevention and treatment of frailty, clinical and preclinical studies on frailty in the future will continue to expand.


Recorded During the Keystone Symposia Conference on

Regenerative Biology and Applications: Cell Differentiation, Tissue Organization and Biomedical Engineering (T3)

Oct 15-19, 2017 | Pok Fu Lam, Hong Kong


This Keystone Symposia SciTalk was made possible by a grant from the Croucher Foundation and The University of Hong Kong.


custom image
custom image

Sequential Immunizations with an Integrase Defective Lentiviral Vector Induce Higher Magnitude and More Durable Antibody Responses than DNA and Protein Based Vaccine Regimens
Maria Blasi, PhD, Duke University Medical Center
Tags: HIV SciTalk

Recorded during the Keystone Symposia meeting:

HIV Vaccines

Mar 26 - Mar 30, 2017 | Steamboat Springs, CO, USA

Population dynamics-species composition, abundance and diversity of Anopheles malaria vectors at Kiimi and Nsadzi islands in Uganda
Krystal Birungi, Uganda Virus Research Institute
Tags: SciTalk Infectious Disease Malaria vectors

Recorded during the Keystone Symposia meeting:

Malaria: From Innovation to Eradication

Feb 19 - Feb 23, 2017 | Kampala, Uganda

Thank you to our collaborator:

e7fb85e095691bff00cbcd6b5f8dc2f4.png

Contributory Role of Socioeconomic Factors in the Development and Spread of Antimalarial Drug Resistance
Philip Anyanwu, University of Sunderland
Tags: SciTalk Infectious Disease Malaria education drug resistance

Recorded during the Keystone Symposia meeting:

Malaria: From Innovation to Eradication

Feb 19 - Feb 23, 2017 | Kampala, Uganda

Thank you to our collaborator:

e7fb85e095691bff00cbcd6b5f8dc2f4.png

Veterinary Vaccines: Some Major Needs
Bryan Charleston, PhD, Pirbright Institute
Tags: SciTalk Infectious Disease Pre Meeting Workshop veterinary pathology vaccines ePrimer tropical diseases

Recorded on May 22, 2016

Pre Meeting Workshop Vaccines for Tropical Diseases

May 22 - May 26, 2016 | Cape Town , South Africa

The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.

This Keystone Symposia SciTalk was made possible by a grant from the

78a6cecd9e66ccf69d7b5d80899df6c6.png

T Cell Memory
Yasmine Belkaid, PhD, NIAID, National Institutes of Health
Tags: SciTalk Infectious Disease Pre Meeting Workshop immunology ePrimer tropical diseases

Recorded on May 22, 2016

Pre Meeting Workshop

Vaccines for Tropical Diseases

May 22 - May 26, 2016 | Cape Town , South Africa

The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.

This Keystone Symposia SciTalk was made possible by a grant from the

4da8236e507f8bdfc3ab2db95c69b9a8.png

How Genetics Helps Us Understand Malaria
Sarah K. Volkman, ScD, Harvard T.H. Chan School of Public Health
Tags: SciTalk Infectious Disease Pre Meeting Workshop Malaria ePrimer genetics

Recorded on February 19, 2017

Pre Meeting Workshop

Malaria: From Innovation to Eradication

Feb 19 - Feb 23, 2017 | Kampala, Uganda

View and Download Presentation

This Keystone Symposia SciTalk was made possible by a grant from the

d94d8e746c6b87eead883b002472a674.png


The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.


  • Displaying 20 - 30 of 55
  • First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last